B. Riley Securities resumed coverage on Rogers Corp with a new price target
$ROG
Major Chemicals
Industrials
B. Riley Securities resumed coverage of Rogers Corp with a rating of Buy and set a new price target of $180.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/14/2023 | $185.00 | Market Outperform | CJS Securities |
| 2/14/2023 | $180.00 | Buy | B. Riley Securities |
| 12/14/2021 | $277.00 | Market Outperform → Market Perform | CJS Securities |
| 11/4/2021 | $225.00 → $277.00 | Buy → Hold | Stifel |
| 11/4/2021 | $233.00 → $277.00 | Buy → Hold | Canaccord Genuity |
| 11/3/2021 | Outperform → Peer Perform | Wolfe Research | |
| 7/30/2021 | $260.00 → $233.00 | Buy | Canaccord Genuity |
ANDOVER, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that transform our world, today announced that Ram Mayampurath has been appointed Executive Vice President, Chief Financial Officer and Treasurer, effective October 14, 2024. He will report directly to John T.C. Lee, President and Chief Executive Officer, and will be a member of MKS' executive team. A global business leader with more than 25 years of experience in financial strategy, thought leadership, and value creation for shareholders and stakeholders, Mr. Mayampurath will join MKS from Rogers Corporation (NYSE:ROG), where he most recently served as Senior Vice P
Veteran Operations Executive Larry Schmid to Lead Rogers' Global Operations and Supply Chain Management Rogers Corporation (NYSE:ROG) ("Rogers") today announced the appointment of Larry Schmid as Senior Vice President, Global Operations and Supply Chain. In this role, Mr. Schmid will direct the operational and supply chain organizations across Rogers' global operations, including in the U.S, China, Belgium, Germany, England, South Korea and Hungary. He will also implement Rogers' ongoing operational excellence initiatives to improve financial performance. "We are pleased to welcome Larry to Rogers and benefit from his more than 20 years of experience in global manufacturing operations and
Colin Gouveia to be Appointed President and CEO; Bruce Hoechner to Retire at Year End Rogers Corporation (NYSE:ROG) ("Rogers") today announced that Bruce D. Hoechner, President and Chief Executive Officer, has decided to retire, effective December 31, 2022. The Rogers Board of Directors plans to appoint Colin Gouveia, Senior Vice President and General Manager of Rogers' Elastomeric Material Solutions (EMS) business unit, to succeed him. To support a smooth transition process, Mr. Hoechner will remain as a member of the Board of Directors and act in an advisory capacity at the Company until March 31, 2023. This press release features multimedia. View the full release here: https://www.busin
4 - ROGERS CORP (0000084748) (Issuer)
4 - ROGERS CORP (0000084748) (Issuer)
3 - ROGERS CORP (0000084748) (Issuer)
CJS Securities initiated coverage of Rogers Corp with a rating of Market Outperform and set a new price target of $185.00
B. Riley Securities resumed coverage of Rogers Corp with a rating of Buy and set a new price target of $180.00
CJS Securities downgraded Rogers Corp from Market Outperform to Market Perform and set a new price target of $277.00
The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay detects the folate receptor 1 protein (FOLR1 or FRɑ), which is over-expressed in most ovarian cancers.The test identifies ovarian cancer patients eligible for targeted treatment with ELAHERE.This certification follows the unprecedented decision by regulators to grant an early exemption approval for the test in Germany and Austria earlier this year.TUCSON, Ariz., Nov. 18, 2024 /PRNewswire/ -- Roche ((SIX: RO, ROG, OTCQX:RHHBY) announced today that it has received CE Mark for its VENTANA® FOLR1 (FOLR1-2.1) RxDx Assay. This is the first immunohistochemistry (IHC) companion diagnostic test to be made widely available in Europe to aid in identifying epithe
Improved Operating Margin Drives Further Earnings Growth Rogers Corporation (NYSE:ROG) today announced financial results for the third quarter of 2024. "Third-quarter results were mixed with earnings that exceeded our guidance expectations and sales that were below the low end of our outlook," stated Colin Gouveia, Rogers' President and CEO. "The higher earnings resulted from our ongoing focus on operational improvements, improved product mix, and careful expense management. Sales for the quarter were lower than expected due to softer EV/HEV demand and a lower seasonal peak in portable electronics sales. Looking ahead to the fourth quarter, we expect sales to decline due to typical season
The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers and helps predict the likelihood of response to targeted therapy.As the leader in companion diagnostics, Roche continues to build on its commitment to improve personalised healthcare to enable better patient outcomes.TUCSON, Ariz., Oct. 18, 2024 /PRNewswire/ -- Roche ((SIX: RO, ROG, OTCQX:RHHBY) announced today that the VENTANAⓇ CLDN18 (43-14A) RxDx Assay is the first U.S. Food and Drug Administration (FDA) a
Improved Operating Margin Drives Further Earnings Growth Rogers Corporation (NYSE:ROG) today announced financial results for the third quarter of 2024. "Third-quarter results were mixed with earnings that exceeded our guidance expectations and sales that were below the low end of our outlook," stated Colin Gouveia, Rogers' President and CEO. "The higher earnings resulted from our ongoing focus on operational improvements, improved product mix, and careful expense management. Sales for the quarter were lower than expected due to softer EV/HEV demand and a lower seasonal peak in portable electronics sales. Looking ahead to the fourth quarter, we expect sales to decline due to typical season
Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President and Chief Executive Officer, who will be joined by Laura Russell, Interim Chief Financial Officer. A live webcast of the event and related slide presentation can be accessed on Rogers' Investor Relations website at https://rogerscorp.com/investors. A replay of the event will also be available on the Investor Relations' website. About Rogers Corporation Rogers Corporation (NYSE:ROG) is a global leader in engineered materials to power, protect and connect
Stronger Gross Margin Drives Improved Results Rogers Corporation (NYSE:ROG) today announced financial results for the second quarter of 2024. "Solid execution contributed to results that were in line with our second quarter expectations," stated Colin Gouveia, Rogers' President and CEO. "Sales were near the mid-point of our Q2 guidance, as stronger portable electronics and wireless infrastructure revenues were tempered by lower general industrial demand. We achieved record quarterly sales of our leading EV battery solutions, but overall EV/HEV results were mixed as power substrate sales declined due to elevated customer inventory levels. Stronger gross margin results drove higher earnin
10-Q - ROGERS CORP (0000084748) (Filer)
8-K - ROGERS CORP (0000084748) (Filer)
8-K - ROGERS CORP (0000084748) (Filer)
SC 13G/A - ROGERS CORP (0000084748) (Subject)
SC 13G/A - ROGERS CORP (0000084748) (Subject)
SC 13G - ROGERS CORP (0000084748) (Subject)
Rogers will continue to support its advanced circuit materials customers through its existing footprint in China and the U.S. These actions are expected to improve operating profit between $7 to $9 million annually, once fully implemented. To achieve these savings the Company expects to incur total charges in the range of $18 to $28 million, comprised of employee severance and related shutdown expenses.
Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results. Aon posted adjusted earnings of $5.66 per share, missing market estimates of $5.91 per share. The company's sales came in at $4.070 billion versus expectations of $4.126 billion, according to data from Benzinga Pro. Aon shares dipped 7.4% to $283.19 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares jumped 73.3% to $1.2475 after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa. Pineapple Energy Inc. (NASDAQ
U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday. Shares of Skechers U.S.A., Inc. (NYSE:SKX) rose sharply during Friday's session after the company reported better-than-expected first-quarter FY24 earnings. Skechers reported first-quarter FY24 sales growth of 12.5% year-on-year to $2.251 billion, beating the analyst consensus estimate of $2.204 billion. EPS of $1.33 beat the analyst consensus of $1.10, according to data from Benzinga Pro. Skechers raised FY24 sales outlook from $8.60 billion-$8.80 billion to $8.725 billion-$8.875 billion, against an estimate of $8.781 billion. The company also raised FY24 EPS outlook from $3.65-$3.85 to $3.95-4.10 versus